Other

Change in Inventories

Vertex Pharmaceuticals Change in Inventories remained flat by 0.0% to $131.05M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.3%, from $129.33M to $131.05M. Over 2 years (FY 2023 to FY 2025), Change in Inventories shows an upward trend with a 27.4% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

An increase in inventory may signal anticipated growth or, conversely, an inability to sell products as expected.

Detailed definition

Measures the net change in the value of raw materials, work-in-progress, and finished goods held by the company. This me...

Peer comparison

Highly comparable across manufacturing and industrial peers; used to calculate inventory turnover ratios.

Metric ID: is_cvx_change_in_inventories

Historical Data

3 years
 FY'23FY'24FY'25
Value$322.90M$517.30M$524.20M
YoY Change—+60.2%+1.3%
Range$322.90M – $524.20M
CAGR+27.4%
Avg YoY Growth+30.8%
Median YoY Growth+30.8%
Current Streak2+ years growth

Change in Inventories at Other Companies

GLW
CorningGLWView metric

Frequently Asked Questions

What is Vertex Pharmaceuticals's change in inventories?
Vertex Pharmaceuticals (VRTX) reported change in inventories of $131.05M in Q4 2025.
How has Vertex Pharmaceuticals's change in inventories changed year-over-year?
Vertex Pharmaceuticals's change in inventories increased by 1.3% year-over-year, from $129.33M to $131.05M.
What is the long-term trend for Vertex Pharmaceuticals's change in inventories?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's change in inventories has grown at a 27.4% compound annual growth rate (CAGR), from $322.90M to $524.20M.
What does change in inventories mean?
The net change in the value of goods held in stock during the period.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.